Evidence map›Paper›PMID 33753887›Full record

ArticleInternational journal of obesity (2005)2021

ω-3PUFA supplementation ameliorates adipose tissue inflammation and insulin-stimulated glucose disposal in subjects with obesity: a potential role for apolipoprotein E.

James D Hernandez, Ting Li, Cassandra M Rau, William E LeSuer, Panwen Wang, Dawn K Coletta, James A Madura, Elizabeth A Jacobsen, Eleanna De Filippis

Open access · hybridAbstract read
In one paragraph

Article in International journal of obesity (2005), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Peptide-functionalized nanoemulsions with exendin-4 as a model ligand.International journal of pharmaceutics: X · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Anti-inflammatory effect of fish oil in human adipose tissue.International journal of obesity (2005) · 2021
    Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

James D HernandezDivision of Endocrinology and Metabolism, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Ting LiDivision of Endocrinology and Metabolism, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Cassandra M RauArizona State University, Barrett, The Honors College, Tempe, AZ, USA.
William E LeSuerDivision of Allergy and Immunology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Panwen WangDepartment of Biostatistics, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Dawn K ColettaDepartment of Medicine, College of Medicine, University of Arizona, Tucson, AZ, USA.
James A MaduraDivision of General Surgery, Mayo Clinic Arizona, Phoenix, AZ, USA.
Elizabeth A JacobsenDivision of Allergy and Immunology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Eleanna De FilippisDivision of Endocrinology and Metabolism, Mayo Clinic Arizona, Scottsdale, AZ, USA. defilippis.elena@mayo.edu.ORCID http://orcid.org/0000-0002-5622-6709
Mayo Clinic in Arizona · USArizona State University · USMayo Clinic in Florida · USUniversity of Arizona · US

Funding

ZESTRIL VS. VERAPAMIL IN THE TREATMENT OF HYPERTENSIONM01RR000585 · NCRR · MAYO CLINIC ROCHESTER · PI RIZZA, ROBERT A. · 1985 to 2006
$30.4M
Institutional Career Development CoreKL2TR002379 · NCATS · MAYO CLINIC ROCHESTER · PI NILUFER ERTEKIN-TANER · 2017 to 2026
$14.9M
NCATS NIH HHS KL2 TR002379NCRR NIH HHS M01 RR000585
6 · The paper itself

Abstract

backgroundLong chain omega-3 polyunsaturated fatty acids (ω-3PUFA) supplementation in animal models of diet-induced obesity has consistently shown to improve insulin sensitivity. The same is not always reported in human studies with insulin resistant (IR) subjects with obesity.

objectiveWe studied whether high-dose ω-3PUFA supplementation for 3 months improves insulin sensitivity and adipose tissue (AT) inflammation in IR subjects with obesity.

methodsThirteen subjects (BMI = 39.3 ± 1.6 kg/m

resultsPalmitic and stearic acid plasma levels were significantly reduced (P < 0.05) after ω-3PUFA. Gene expression of pro-inflammatory markers and adipokines were improved after ω-3PUFA (P < 0.05). Systemic inflammation was decreased after ω-3PUFA, as shown by cytokine assessment (P < 0.05). These changes were associated with a 25% increase in insulin-stimulated glucose disposal (4.7 ± 0.6 mg/kg ffm•min vs. 5.9 ± 0.9 mg/kg ffm•min) despite no change in body weight. Microarray analysis identified 53 probe sets significantly altered post- ω-3PUFA, with Apolipoprotein E (APOE) being one of the most upregulated genes.

conclusionHigh dose of long chain ω-3PUFA supplementation modulates significant changes in plasma fatty acid profile, AT, and systemic inflammation. These findings are associated with significant improvement of insulin-stimulated glucose disposal. Unbiased microarray analysis of Sc fat biopsy identified APOE as among the most differentially regulated gene after ω-3PUFA supplementation. We speculate that ω-3PUFA increases macrophage-derived APOE mRNA levels with anti-inflammatory properties.

Indexed as

Adipose TissueFatty Acids, Omega-3AdultApolipoproteins EBlood GlucoseFemaleHumansInflammationInsulin ResistanceMaleObesitySubcutaneous FatTranscriptomeApolipoproteins EBlood GlucoseFatty Acids, Omega-3

Identifiers

PMID33753887
PMCPMC8159741
OpenAlexW3138098408

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.